When did Alkermes report Q1 2026 earnings?

Alkermes (ALKS) reported Q1 2026 earnings on May 5, 2026 before market open.

What were Alkermes's Q1 2026 revenue and EPS?

Alkermes reported revenue of $392.9M and eps of $-0.40 for Q1 2026.

Did Alkermes beat estimates in Q1 2026?

Revenue beat the consensus estimate of $363.1M by $29.9M. EPS beat the consensus estimate of $-0.57 by $0.17.

How did Alkermes's Q1 2026 results compare year-over-year?

Compared to the same quarter a year prior, revenue grew 28.2% from $306.5M a year earlier.

Where can I find Alkermes's Q1 2026 SEC filings?

You can read the 8-K earnings release (0001193125-26-205008) and the 10-Q periodic report (0001193125-26-206534) directly on SEC EDGAR. The filing index links above go to sec.gov.

Alkermes ALKS Q1 2026 earnings

Reported May 5, 2026 · Before market open

Revenue$392.9MBeat by $29.9M

EPS-$0.40Beat by $0.17

Revenue estimate$363.1M

EPS estimate-$0.57

Next report

Oct 27, 2026 (in 3 months)

Revenue estimate$467.0M

EPS estimate$0.01

Financials

Q1 2026

Income statement

See full

Revenue$392.9M+28.2%

Gross profit$331.3M+28.8%

Operating income-$48.3M-450%

Net income-$66.5M-396%

EPS (diluted)-$0.40-408%

Balance sheet

See full

Cash & equivalents$351.6M-12.1%

Total debt$1.6B+2,034%

Total equity$1.8B+15.9%

Total assets$4.3B+105%

Cash flow

See full

Operating cash flow-$165.7M-268%

CapEx$4.1M-59.5%

Free cash flow-$169.8M-291%

Valuation & ratios

Valuation

as of 03/31/26

See full

Market cap$5.89B+9.7%

Enterprise value$7.12B+41.2%

P/E38.6×+23.4×

P/S3.8×+0.2×

Profitability

See full

Gross margin86.6%+2.2pp

Operating margin12.3%-13.6pp

Net margin9.8%-13.5pp

FCF margin14.2%-17.6pp

Returns & leverage

See full

Return on equity9.4%-16.1pp

Debt / equity0.9×+0.9×

Current ratio2.3×-1.1×

Segments

By product

See full

Vivitrol$112.4M—

Aristada And Aristada Initio$93.8M—

LYBALVI$92.4M—

LUMRYZ$39.5M—

Versus estimates

Revenue

Q2 2026$496.0MBeat by $38.6M

Q1 2026$392.9MBeat by $29.9M

Q4 2025$384.5MBeat by $5.6M Q3 2025$394.2MBeat by $14.3M Q2 2025$390.7MBeat by $36.1M Q1 2025$306.5MBeat by $3.6M

Diluted EPS

Q2 2026$0.70Beat by $0.73

Q1 2026-$0.40Beat by $0.17

Q4 2025$0.34Miss by $0.09 Q3 2025$0.49Beat by $0.07 Q2 2025$0.52Beat by $0.11 Q1 2025$0.13Miss by $0.12

Ask the moment Alkermes reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did Alkermes report Q1 2026 earnings?: Alkermes (ALKS) reported Q1 2026 earnings on May 5, 2026 before market open.
What were Alkermes's Q1 2026 revenue and EPS?: Alkermes reported revenue of $392.9M and eps of $-0.40 for Q1 2026.
Did Alkermes beat estimates in Q1 2026?: Revenue beat the consensus estimate of $363.1M by $29.9M. EPS beat the consensus estimate of $-0.57 by $0.17.
How did Alkermes's Q1 2026 results compare year-over-year?: Compared to the same quarter a year prior, revenue grew 28.2% from $306.5M a year earlier.
Where can I find Alkermes's Q1 2026 SEC filings?: You can read the 8-K earnings release (0001193125-26-205008) and the 10-Q periodic report (0001193125-26-206534) directly on SEC EDGAR. The filing index links above go to sec.gov.